Published in Blood Weekly, December 28th, 1998
The work is at a very early stage, however, indicated Michael C. Marden, Director of Research for INSERM, France, at the Blood Safety-Europe Conference, sponsored by Cambridge Healthtech Institute, and held November 16-17, 1998, in Lisbon, Portugal.
As part of a large project to develop an alternate source of hemoglobin (Hb), Marden and colleagues co-expressed the alpha and beta globins of human Hb A in transgenic tobacco plants.
Through the use of Western blotting, the researchers were able to detect globin chains in extracts from seeds (up to 0.05...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.